Authors:
Davies, PJA
Berry, SA
Shipley, GL
Eckel, RH
Hennuyer, N
Crombie, DL
Ogilvie, KM
Peinado-Onsurbe, J
Fievet, C
Leibowitz, MD
Heyman, RA
Auwerx, J
Citation: Pja. Davies et al., Metabolic effects of rexinoids: Tissue-specific regulation of lipoprotein lipase activity, MOLEC PHARM, 59(2), 2001, pp. 170-176
Citation: Pl. Bergad et al., Yin-yang 1 and glucocorticoid receptor participate in the Stat5-mediated growth hormone response of the serine protease inhibitor 2.1 gene, J BIOL CHEM, 275(11), 2000, pp. 8114-8120
Authors:
Zhou, G
Chen, YQ
Zhou, L
Thirunavukkarasu, K
Hecht, J
Chitayat, D
Gelb, BD
Pirinen, S
Berry, SA
Greenberg, CR
Karsenty, G
Lee, B
Citation: G. Zhou et al., CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia, HUM MOL GEN, 8(12), 1999, pp. 2311-2316
Authors:
Berry, SA
Bergad, PL
Stolz, AM
Towle, HC
Schwarzenberg, SJ
Citation: Sa. Berry et al., Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: discordant responses to IL-6, AM J P-CELL, 45(6), 1999, pp. C1374-C1382
Authors:
Willins, DL
Berry, SA
Alsayegh, L
Backstrom, JR
Sanders-Bush, E
Friedman, L
Roth, BL
Citation: Dl. Willins et al., Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo, NEUROSCIENC, 91(2), 1999, pp. 599-606
Authors:
Georgieff, MK
Berry, SA
Wobken, JD
Leibold, EA
Citation: Mk. Georgieff et al., Increased placental iron regulatory protein-1 expression in diabetic pregnancies complicated by fetal iron deficiency, PLACENTA, 20(1), 1999, pp. 87-93
Authors:
Schulz, SC
Camlin, KL
Berry, SA
Jesberger, JA
Citation: Sc. Schulz et al., Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia, BIOL PSYCHI, 46(10), 1999, pp. 1429-1435